NF-kB Activation Inhibitor VI, BOT-64(113760-29-5)
- Name: NF-kB Activation Inhibitor VI, BOT-64
- Synonyms:1,3-Benzoxathiol-4(5H)-one,6,7-dihydro-6,6-dimethyl-2-(phenylimino);6,6-dimethyl-2-(phenylimino)-6,7-dihydro-5H-benzo[1,3]oxathiol-4-one;6,6-dimethyl-2-(phenylimino)-6,7-dihydrobenzo[d][1,3]oxathiol-4(5H)-one;2-phenylimino-4-oxo-4,5,6,7-tetrahydro-6,6-dimethyl-1,3-benzoxathiole;
- Molecular Formula:C15H15NO2S
- Molecular Weight:273.356
- CAS Registry Number:113760-29-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 113760-09-1/Ethanol, 2,2'-[(2,3-dihydro-2,3,5,6-tetraphenyl-1,4-dioxin-2,3-diyl)bis(oxy)]bis-
- 113760-10-4/1,4-Dioxin, 2,3-dihydro-2,3-dimethoxy-2,3,5,6-tetraphenyl-, trans-
- 113760-11-5/Propanoic acid, 2-[4-[(3-fluoro-2-quinoxalinyl)oxy]phenoxy]-, ethyl ester
- 113760-12-6/Propanoic acid, 2-[4-[(3-chloro-2-quinoxalinyl)oxy]phenoxy]-, ethyl ester
- 113760-14-8/Propanoic acid, 2-[4-[(6-chloro-3,4-dihydro-3-oxo-2-quinoxalinyl)oxy]phenoxy]-, ethyl ester
- 113760-15-9/Propanoic acid, 2-[4-[(3,6-dichloro-2-quinoxalinyl)oxy]phenoxy]-, ethyl ester
- 113760-16-0/Propanoic acid, 2-[4-[(3-methyl-2-quinoxalinyl)oxy]phenoxy]-, ethyl ester
- 113760-17-1/Quinazoline, 4-(methylthio)-2-phenyl-, 3-oxide
- 113760-18-2/Quinazoline, 2-(4-methylphenyl)-4-(methylthio)-, 3-oxide
- 113760-19-3/2H-Isoxazolo[2,3-c]quinazoline-1-carbonitrile, 2-imino-5-phenyl-
- 113760-20-6/2H-Isoxazolo[2,3-c]quinazoline-1-carbonitrile, 2-imino-5-(4-methylphenyl)-
- 113760-21-7/2H-Isoxazolo[2,3-c]quinazoline-1-carboxamide, 2-imino-5-phenyl-
- 113760-22-8/2H-Isoxazolo[2,3-c]quinazoline-1-carboxamide, 2-imino-5-(4-methylphenyl)-
- 113760-23-9/2H-Isoxazolo[2,3-c]quinazolin-2-one, 1-acetyl-5-phenyl-
- 113760-24-0/2H-Isoxazolo[2,3-c]quinazolin-2-one, 1-acetyl-5-(4-methylphenyl)-
- 113760-25-1/2H-Isoxazolo[2,3-c]quinazoline-1-carboxylic acid, 2-oxo-5-phenyl-, ethyl ester
- 113760-26-2/2H-Isoxazolo[2,3-c]quinazoline-1-carboxylic acid, 5-(4-methylphenyl)-2-oxo-, ethyl ester
- 113760-27-3/2H-Isoxazolo[2,3-c]quinazoline-1-carbonitrile, 2-oxo-5-phenyl-
- 113760-28-4/2H-Isoxazolo[2,3-c]quinazoline-1-carbonitrile, 5-(4-methylphenyl)-2-oxo-
- 113760-29-5/NF-kB Activation Inhibitor VI, BOT-64
- 113760-30-8/4(2H)-Benzofuranone, 3,5,6,7-tetrahydro-6,6-dimethyl-2-phenyl-3-(2-phenylethenyl)-
- 113760-31-9/1,3-Cyclohexanedione, 2,2'-(1,2,4,5-tetrathiane-3,6-diylidene)bis[5,5-dimethyl-
- 113760-33-1/2-Morpholinecarboxamide, N,N-diethyl-6-(1H-indol-4-yl)-4-methyl-
- 113760-40-0/Carbamic acid, [2-hydroxy-2-(1H-indol-4-yl)ethyl]-, methyl ester
- 113760-41-1/1H-Indole-4-methanol, a-(aminomethyl)-, (E)-2-butenedioate (salt)
- 113760-42-2/Carbamic acid, [2-(2,3-dihydro-1H-indol-4-yl)-2-hydroxyethyl]-, methyl ester
- 113760-43-3/Carbamic acid, [2-(1-benzoyl-2,3-dihydro-1H-indol-4-yl)-2-hydroxyethyl]-, methyl ester
- 113760-44-4/1H-Indole-4-methanol, 2,3-dihydro-a-[(methylamino)methyl]-1-(2-phenylethyl)-
- 113760-45-5/1H-Indole-4-methanol, a-[(methylamino)methyl]-1-(2-phenylethyl)-, hydrochloride
- 113760-46-6/Propanoic acid, 3-[[2-[2,3-dihydro-1-(phenylmethyl)-1H-indol-4-yl]-2-hydroxyethyl]methyl amino]-2-hydroxy-, ethyl ester